Claret Asset Management Corp Bio Rad Laboratories, Inc. Transaction History
Claret Asset Management Corp
- $772 Million
- Q2 2025
A detailed history of Claret Asset Management Corp transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Claret Asset Management Corp holds 953 shares of BIO stock, worth $297,707. This represents 0.03% of its overall portfolio holdings.
Number of Shares
953Holding current value
$297,707% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
426Shares Held
19.2MCall Options Held
10.7KPut Options Held
35.5K-
First Eagle Investment Management, LLC2.52MShares$786 Million1.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$577 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$484 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1MShares$312 Million0.06% of portfolio
-
Veritas Asset Management LLP863KShares$270 Million2.27% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.7B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...